Presentation
The Paris Transplant Group (PTG) is developing a personalized approach for transplant medicine that integrates multidimensional information derived from standard of care (clinical and biological data, histology and immunology) together with novel information coming from cutting edge technologies in immunology, molecular biology, genetics and biomarkers.
The team includes several departments in kidney, heart, lung and liver transplantation, which are known as reference centres.
Kidney transplant
Our consortium includes leading national kidney transplant centers totalling more than 530 transplants each year
Heart transplant
The centers dedicated to heart transplant represent more than 80% of the overall national heart transplant activity (150 transplants each year).
Lung transplant
Our consortium includes leading transplant centers with more than 75 transplants each year.
Liver transplant
Our consortium of liver transplant centers, collaborating seamlessly, conducts over 400 liver transplant procedures annually.
PTG builts the largest comprehensive multi-organ cohort worldwide.
More than
Latest News of the Research Team
Connect with us on Twitter
Direct from Choose Europe đȘđșfor Science: A Bold Step from Paris đ«đ· !
Transplant researchers: if youâre ready to innovate, đ«đ· might be your next destinationđŹ.
@ParisTxGroup is ready đđ€đŠŸ#PITOR #FranceForScience DM me if interested
Our study on Microvascular Inflammation of Kidney Allografts and Clinical Outcomes is now published in print! đâš
Alongside it, a must-read editorial dives into the evolving landscape of antibody-mediated rejection
A summary đ§”đ
New in the February 20, 2025, issue of NEJM:
Catheter Ablation for Ventricular Tachycardia (VANISH2 trial) https://nej.md/3Z5ECOD
Acalabrutinib Combinations in Untreated CLL (AMPLIFY phase 3 trial) https://nej.md/3Q55fOs
Microvascular Inflammation of Kidney AllograftsâŠ
@devisomey
Interested in our teamâs @NEJM publication on microvascular inflammation in kidney allografts and its clinical outcomes? Check out the coverage in @pathologistmag, highlighting the key findings and the studyâs impact.
https://thepathologist.com/subspecialties/signs-of-rejection
It was a pleasure to be part of the Advances in Transplant Medecine Symposium #Zagreb, presenting on liver transplant rejection.
Great to participate and meet new colleagues from University Hospital Center Zagrebđđ·
@ProfNikolinaBaĆĄiÄ-JukiÄ, Ivana Juric
@A_Sannier
@ParisTxGroup
I had the privilege of being invited to give a lecture @karolinskainst đžđȘ Truly honored and inspired to stand so close to the building where the The Nobel Prize are being awarded this week.
A special shoutout to @Gabriel Oniscu @ESOTtransplant for his exceptional leadership.
đ This weekend don't miss our @Kidney_Int #ISNFridaySelection: Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN) https://www.kidney-international.org/article/S0085-2538(24)00565-9/fulltext
Pleased to see our recent publication in @NEJM on the clinical outcomes of microvascular inflammation featured by @louise_benning and @OriolBestard in the News and Views Section of @Transpl_Int
đ«Throwback to @ASNKidney #kidneywk in âïžSanDiego this year-listening to @A_Sannier presenting the latest @ParisTxGroup @NEJM on đoutcomes in patients with #mvi! Honored to now publish this commentary with @OriolBestard at @ESOTtransplant @Transpl_Int đhttps://www.frontierspartnerships.org/journals/transplant-international/articles/10.3389/ti.2024.14032/full?utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field&journalName=Transplant_International&id=14032
Thrilled to see @EUTRAIN_project's contributions featured in a recent study, which identifies phenotypes in kidney transplant recipients to enhance diagnostic precision and optimise patient care! @HorizonEU @AlexandreLoupy
https://x.com/NEJM/status/1849595491320988037
